Growth Metrics

Lexicon Pharmaceuticals (LXRX) Inventory Average (2023 - 2025)

Lexicon Pharmaceuticals (LXRX) has disclosed Inventory Average for 3 consecutive years, with $219500.0 as the latest value for Q4 2025.

  • On a quarterly basis, Inventory Average fell 49.37% to $219500.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $219500.0, a 49.37% decrease, with the full-year FY2025 number at $256000.0, down 16.34% from a year prior.
  • Inventory Average was $219500.0 for Q4 2025 at Lexicon Pharmaceuticals, up from $163000.0 in the prior quarter.
  • In the past five years, Inventory Average ranged from a high of $610500.0 in Q3 2024 to a low of $163000.0 in Q3 2025.
  • A 3-year average of $343650.0 and a median of $306250.0 in 2023 define the central range for Inventory Average.
  • Peak YoY movement for Inventory Average: surged 140.35% in 2024, then plummeted 73.3% in 2025.
  • Lexicon Pharmaceuticals' Inventory Average stood at $358500.0 in 2023, then increased by 20.92% to $433500.0 in 2024, then crashed by 49.37% to $219500.0 in 2025.
  • Per Business Quant, the three most recent readings for LXRX's Inventory Average are $219500.0 (Q4 2025), $163000.0 (Q3 2025), and $184500.0 (Q2 2025).